95 related articles for article (PubMed ID: 12927682)
1. Marked reduction in serum high-density lipoprotein cholesterol concentrations in a woman with acute inflammation due to diabetic gangrene.
Kobayashi J; Tateishi S; Maruyama T; Kudoh A; Murano S
Clin Chim Acta; 2003 Sep; 335(1-2):33-8. PubMed ID: 12927682
[TBL] [Abstract][Full Text] [Related]
2. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
[TBL] [Abstract][Full Text] [Related]
3. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
4. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
5. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
7. Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.
Yan PJ; Xu Y; Wan Q; Feng J; Li H; Gao CL; Yang J; Zhong HH; Zhang ZH
Acta Diabetol; 2017 Dec; 54(12):1091-1099. PubMed ID: 28918492
[TBL] [Abstract][Full Text] [Related]
8. Levels of High-Density Lipoprotein Cholesterol are Associated With Biomarkers of Inflammation in Patients With Acute Coronary Syndrome.
González-Pacheco H; Amezcua-Guerra LM; Vazquez-Rangel A; Martínez-Sánchez C; Pérez-Méndez O; Verdejo J; Bojalil R
Am J Cardiol; 2015 Dec; 116(11):1651-7. PubMed ID: 26456205
[TBL] [Abstract][Full Text] [Related]
9. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
von Eynatten M; Schneider JG; Humpert PM; Rudofsky G; Schmidt N; Barosch P; Hamann A; Morcos M; Kreuzer J; Bierhaus A; Nawroth PP; Dugi KA
Diabetes Care; 2004 Dec; 27(12):2925-9. PubMed ID: 15562208
[TBL] [Abstract][Full Text] [Related]
10. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
[TBL] [Abstract][Full Text] [Related]
11. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
12. Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus.
Kasim SE; Tseng K; Jen KL; Khilnani S
J Clin Endocrinol Metab; 1987 Jul; 65(1):183-7. PubMed ID: 3584394
[TBL] [Abstract][Full Text] [Related]
13. Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children.
Agirbasli M; Tanrikulu A; Acar Sevim B; Azizy M; Bekiroglu N
J Clin Lipidol; 2015; 9(2):195-200. PubMed ID: 25911075
[TBL] [Abstract][Full Text] [Related]
14. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cardiovascular risk markers in women with hypopituitarism.
Sesmilo G; Miller KK; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2001 Dec; 86(12):5774-81. PubMed ID: 11739438
[TBL] [Abstract][Full Text] [Related]
16. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
[TBL] [Abstract][Full Text] [Related]
17. Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactions.
Johnsson H; Panarelli M; Cameron A; Sattar N
Ann Rheum Dis; 2014 Aug; 73(8):1495-9. PubMed ID: 23716069
[TBL] [Abstract][Full Text] [Related]
18. A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients.
Ma YH; Zhao L; Xian XD; Yang D; Huang W; Wang YH; Mueller O; Chang E; Konigshofer Y; Van-Cleve M; Liu G; Yang JK
Clin Chem Lab Med; 2009; 47(9):1067-72. PubMed ID: 19728847
[TBL] [Abstract][Full Text] [Related]
19. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
